Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof; Commission Determination Not To Review an Initial Determination Granting an Amended Motion To Terminate the Remaining Respondents Based on a Consent Order; Issuance of Consent Order and Termination of the Investigation, 49763-49764 [2013-19775]

Download as PDF Federal Register / Vol. 78, No. 158 / Thursday, August 15, 2013 / Notices removal of unexploded ordnance. Safety will be ensured by only permitting controlled, refuge-guided activities in cleared areas. We will acquire an openwater boat capable of reaching the island to provide for extended visits. This alternative will add a half-time public use or park ranger position and a half-time manager position to be shared with the Caribbean Islands National Wildlife Refuge Complex. Authority This notice is published under the authority of the National Wildlife Refuge System Improvement Act of 1997 (16 U.S.C. 668dd et seq.). Dated: April 25, 2013. Mike Oetker, Acting Regional Director. [FR Doc. 2013–19808 Filed 8–14–13; 8:45 am] BILLING CODE 4310–55–P DEPARTMENT OF THE INTERIOR Bureau of Land Management [AA–6691–I; LLAK940000–L14100000– HY0000–P] Alaska Native Claims Selection Bureau of Land Management, Interior. ACTION: Notice of decision approving lands for conveyance. AGENCY: As required by 43 CFR 2650.7(d), notice is hereby given that the Bureau of Land Management (BLM) will issue an appealable decision to convey certain lands to Oceanside Corporation. The decision approves the surface estate in the lands described below for conveyance pursuant to the Alaska Native Claims Settlement Act (43 U.S.C. 1601, et seq). The subsurface estate in these lands will be conveyed to Bristol Bay Native Corporation when the surface estate is conveyed to Oceanside Corporation. The lands are in the vicinity of Perryville, Alaska, and are located in: SUMMARY: emcdonald on DSK67QTVN1PROD with NOTICES Seward Meridian, Alaska T. 48 S., R. 65 W., Sec. 21. Containing 640 acres. Notice of the decision will also be published once a week for four consecutive weeks in the Anchorage Daily News. DATES: Any party claiming a property interest in the lands affected by the decision may appeal the decision in accordance with the requirements of 43 CFR part 4 within the following time limits: VerDate Mar<15>2010 17:43 Aug 14, 2013 Jkt 229001 1. Unknown parties, parties unable to be located after reasonable efforts have been expended to locate, parties who fail or refuse to sign their return receipt, and parties who receive a copy of the decision by regular mail which is not certified, return receipt requested, shall have until September 16, 2013 to file an appeal. 2. Parties receiving service of the decision by certified mail shall have 30 days from the date of receipt to file an appeal. Parties who do not file an appeal in accordance with the requirements of 43 CFR part 4 shall be deemed to have waived their rights. Notices of appeal transmitted by electronic means, such as facsimile or email, will not be accepted as timely filed. ADDRESSES: A copy of the decision may be obtained from: Bureau of Land Management, Alaska State Office, 222 West Seventh Avenue, #13, Anchorage, Alaska 99513–7504. FOR FURTHER INFORMATION CONTACT: The BLM by phone at 907–271–5960 or by email at blm_ak_akso_public_room@blm.gov. Persons who use a Telecommunications Device for the Deaf (TDD) may call the Federal Information Relay Service (FIRS) at 1–800–877–8339 to contact the BLM during normal business hours. In addition, the FIRS is available 24 hours a day, 7 days a week, to leave a message or question with the BLM. The BLM will reply during normal business hours. Joe J. Labay, Land Transfer Resolution Specialist, Division of Lands and Cadastral. [FR Doc. 2013–19838 Filed 8–14–13; 8:45 am] BILLING CODE 4310–JA–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–879] Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof; Commission Determination Not To Review an Initial Determination Granting an Amended Motion To Terminate the Remaining Respondents Based on a Consent Order; Issuance of Consent Order and Termination of the Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to SUMMARY: PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 49763 review an initial determination (‘‘ID’’) (Order No. 11) of the presiding administrative law judge granting an amended motion to terminate the remaining respondents based on a consent order. The Commission has issued the subject consent order; the investigation is hereby terminated. FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–3065. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on May 1, 2013, based on a complaint filed on March 28, 2013, and supplemented on April 19, 2013, on behalf of ResMed Corporation of San Diego, California; ResMed Incorporated of San Diego, California; and ResMed Limited of Australia. 78 FR 25475 (May 1, 2013). The complaint alleged violations of Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the sale for importation, importation, or sale within the United States after importation of certain sleepdisordered breathing treatment systems and components thereof by reason of infringement of one or more of claims 1, 2, 4, 5, 17 and 28 of U.S. Patent No. 6,216,691; claims 1 and 20 of U.S. Patent No. 6,935,337; claim 15 of U.S. Patent No. 7,159,587; claims 1, 5, 6, 11, 12, 18–20, 35 and 36 of U.S. Patent No. 7,487,772; claims 1–7 of U.S. Patent No. 7,614,398; claims 59, 60, 63, 72–75 of U.S. Patent No. 7,743,767; and claims 17, 21–24, 29, 32–37 of U.S. Patent No. 7,997,267. The Commission’s notice of investigation named as respondents Apex Medical Corporation of New Taipei City, Taiwan and Apex Medical USA Corporation of Brea, California (collectively, ‘‘Apex’’) and Medical Depot Inc., d/b/a Drive Medical Design & Manufacturing of Port Washington, E:\FR\FM\15AUN1.SGM 15AUN1 49764 Federal Register / Vol. 78, No. 158 / Thursday, August 15, 2013 / Notices New York. Medical Depot Inc. has previously been terminated from the investigation on the basis of a consent order. On July 2, 2013, Apex filed a motion to terminate the investigation based on a consent order, and on July 5, 2013, filed an amended motion based on a consent order stipulation and proposed consent order. On July 16, 2013, Complainants filed a response in opposition, and the the Commission investigative attorney filed a response in support of the motion. On July 17, 2013, the administrative law judge issued Order No. 11, granting the motion to terminate the investigation and staying the procedural schedule. The administrative law judge found termination to be in the public interest. That part of Order No. 11 which terminates the investigation constitutes an initial determination. There were no petitions for review. Having considered the ID and proposed consent order and the relevant portions of the record, the Commission has determined not to review the subject ID. The Commission has issued the consent order, and the investigation is terminated. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR Part 210). Issued: August 9, 2013. By order of the Commission. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2013–19775 Filed 8–14–13; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–885] Certain Portable Electronic Communications Devices, Including Mobile Phones and Components Thereof; Commission Determination Not To Review n Initial Determination Granting Google, Inc.’s Unopposed Motion To Intervene U.S. International Trade Commission. ACTION: Notice. emcdonald on DSK67QTVN1PROD with NOTICES AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 5) of the presiding administrative law judge (‘‘ALJ’’) SUMMARY: VerDate Mar<15>2010 17:43 Aug 14, 2013 Jkt 229001 granting Google, Inc.’s unopposed motion to intervene. Rules of Practice and Procedure (19 CFR 210.42–.46). FOR FURTHER INFORMATION CONTACT: Issued: August 12, 2013. By order of the Commission. Lisa R. Barton, Acting Secretary to the Commission. Michael Liberman, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–3115. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server at http://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation under section 337 of the Tariff Act of 1930, 19 U.S.C. 1337, on June 26, 2013, based on a complaint filed by Nokia Corporation of Espoo, Finland and Nokia Inc., of Sunnyvale, California (collectively, ‘‘Nokia’’). The complaint, as supplemented, alleges a violation of section 337 by reason of infringement of certain claims of U.S. Patent Nos. 6,035,189 (‘‘the ‘189 patent’’); 6,373,345; 6,711,211 (‘‘the ‘211 patent’’); 7,187,945; 8,140,650 (‘‘the ‘650 patent’’); and 8,363,824. 78 FR 38362 (Jun. 26, 2013). The respondents are HTC Corporation of Taoyuan City, Taiwan, and HTC America, Inc. of Bellevue, Washington (collectively, ‘‘HTC’’). On July 11, 2013, third party Google Inc. (‘‘Google’’) filed a motion to intervene as a party in this investigation with respect to three of the six patents, namely the ‘189, ‘211 and ‘650 patents. The motion states that neither complainants Nokia nor respondents HTC oppose the motion. On July 16, 2013, the ALJ issued an ID (Order No. 5) granting Google’s motion. The ALJ found, inter alia, that the motion was timely filed and that Google has shown that it has a substantial interest in the investigation. No party petitioned for review. The Commission has determined not to review the ID. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in sections 210.42–.46 of the Commission’s PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 [FR Doc. 2013–19825 Filed 8–14–13; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–796] Certain Electronic Digital Media Devices and Components Thereof; Commission’s Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Orders; Termination of the Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 in this investigation and has issued a limited exclusion order prohibiting respondents Samsung Electronics Co, Ltd. of the Republic of Korea (‘‘SEC’’); Samsung Electronics America, Inc. of Ridgefield Park, New Jersey (‘‘SEA’’); and Samsung Telecommunications America, LLC of Richardson, Texas (‘‘STA’’) (collectively, ‘‘Samsung’’), from importing certain electronic digital media devices that infringe one or more of claims 1, 4–6, 10, and 17–20 of U.S. Patent No. 7,479,949 (‘‘the ’949 patent’’) and claims 1–4 and 8 of U.S. Patent No. 7,912,501 (‘‘the ’501 patent’’). The Commission has also issued cease and desist orders prohibiting SEA and STA from further importing, selling, and distributing articles that infringe one or more of claims 1, 4–6, 10, and 17–20 of the ’949 patent and claims 1–4 and 8 of the ’501 patent in the United States. The Commission has found no violation based on U.S. Patent Nos. D618,678 (‘‘the D’678 patent’’); D558,757 (‘‘the D’757 patent’’); RE 41,922 (‘‘the ’922 patent’’); and 7,789,697 (‘‘the ’697 patent’’). The Commission’s determination is final, and the investigation is terminated. FOR FURTHER INFORMATION CONTACT: Cathy Chen, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2392. Copies of non-confidential documents filed in connection with this investigation are or will be available for SUMMARY: E:\FR\FM\15AUN1.SGM 15AUN1

Agencies

[Federal Register Volume 78, Number 158 (Thursday, August 15, 2013)]
[Notices]
[Pages 49763-49764]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19775]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-879]


Certain Sleep-Disordered Breathing Treatment Systems and 
Components Thereof; Commission Determination Not To Review an Initial 
Determination Granting an Amended Motion To Terminate the Remaining 
Respondents Based on a Consent Order; Issuance of Consent Order and 
Termination of the Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 11) of the presiding administrative law judge 
granting an amended motion to terminate the remaining respondents based 
on a consent order. The Commission has issued the subject consent 
order; the investigation is hereby terminated.

FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 205-3065. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on May 1, 2013, based on a complaint filed on March 28, 2013, and 
supplemented on April 19, 2013, on behalf of ResMed Corporation of San 
Diego, California; ResMed Incorporated of San Diego, California; and 
ResMed Limited of Australia. 78 FR 25475 (May 1, 2013). The complaint 
alleged violations of Section 337 of the Tariff Act of 1930, as 
amended, 19 U.S.C. 1337, in the sale for importation, importation, or 
sale within the United States after importation of certain sleep-
disordered breathing treatment systems and components thereof by reason 
of infringement of one or more of claims 1, 2, 4, 5, 17 and 28 of U.S. 
Patent No. 6,216,691; claims 1 and 20 of U.S. Patent No. 6,935,337; 
claim 15 of U.S. Patent No. 7,159,587; claims 1, 5, 6, 11, 12, 18-20, 
35 and 36 of U.S. Patent No. 7,487,772; claims 1-7 of U.S. Patent No. 
7,614,398; claims 59, 60, 63, 72-75 of U.S. Patent No. 7,743,767; and 
claims 17, 21-24, 29, 32-37 of U.S. Patent No. 7,997,267. The 
Commission's notice of investigation named as respondents Apex Medical 
Corporation of New Taipei City, Taiwan and Apex Medical USA Corporation 
of Brea, California (collectively, ``Apex'') and Medical Depot Inc., d/
b/a Drive Medical Design & Manufacturing of Port Washington,

[[Page 49764]]

New York. Medical Depot Inc. has previously been terminated from the 
investigation on the basis of a consent order.
    On July 2, 2013, Apex filed a motion to terminate the investigation 
based on a consent order, and on July 5, 2013, filed an amended motion 
based on a consent order stipulation and proposed consent order. On 
July 16, 2013, Complainants filed a response in opposition, and the the 
Commission investigative attorney filed a response in support of the 
motion. On July 17, 2013, the administrative law judge issued Order No. 
11, granting the motion to terminate the investigation and staying the 
procedural schedule. The administrative law judge found termination to 
be in the public interest. That part of Order No. 11 which terminates 
the investigation constitutes an initial determination.
    There were no petitions for review. Having considered the ID and 
proposed consent order and the relevant portions of the record, the 
Commission has determined not to review the subject ID. The Commission 
has issued the consent order, and the investigation is terminated.
    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Part 210 of the 
Commission's Rules of Practice and Procedure (19 CFR Part 210).

     Issued: August 9, 2013.

    By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2013-19775 Filed 8-14-13; 8:45 am]
BILLING CODE 7020-02-P